{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-25-000070","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.364823+00:00","generated_at":"2026-05-17T06:48:08.925903+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Encompass Health reaffirms FY2025 guidance during investor meetings","bullets":["Net operating revenue guidance of $5.88B-$5.98B for FY2025.","Adjusted EBITDA guided at $1.22B-$1.25B; adjusted EPS $5.12-$5.34.","Reiteration provided at meetings on Sept 12, Oct 1, and Oct 6, 2025.","Previous guidance from Aug 4/5, 2025 remains unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-25-000070","json":"https://secwatch.observer/filing/0000785161-25-000070.json","markdown":"https://secwatch.observer/filing/0000785161-25-000070.md","text":"https://secwatch.observer/filing/0000785161-25-000070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000070/0000785161-25-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000070/ehc-20250912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:48:08.925903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}